In CRC cell lines (HT29, SW-480, and SW620), MORC2 can downregulate the expression of NDRG1, a metastasis suppressor and prognostic biomarker of CRC, by interacting with sirtuin 1 and binding to the NDRG1 promoter. Here, MORC2 is linked to colorectal carcinoma.